160 related articles for article (PubMed ID: 30967102)
21. Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India.
Matlani M; Kojom LP; Mishra N; Dogra V; Singh V
Ann Clin Microbiol Antimicrob; 2020 Oct; 19(1):49. PubMed ID: 33126884
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and clinical manifestations of malaria in Aligarh, India.
Asma UE; Taufiq F; Khan W
Korean J Parasitol; 2014 Dec; 52(6):621-9. PubMed ID: 25548413
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular involvement in severe vivax and falciparum malaria.
Nayak KC; Meena SL; Gupta BK; Kumar S; Pareek V
J Vector Borne Dis; 2013 Dec; 50(4):285-91. PubMed ID: 24499851
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand.
Srivastava S; Ahmad S; Shirazi N; Kumar Verma S; Puri P
Acta Trop; 2011 Feb; 117(2):82-5. PubMed ID: 20943199
[TBL] [Abstract][Full Text] [Related]
25. Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax.
Guedes KS; Sanchez BAM; Gomes LT; Fontes CJF
PLoS One; 2019; 14(11):e0224877. PubMed ID: 31765438
[TBL] [Abstract][Full Text] [Related]
26. Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in Western Uttar Pradesh, India.
Rizvi I; Tripathi DK; Chughtai AM; Beg M; Zaman S; Zaidi N
Ann Afr Med; 2013; 12(3):155-9. PubMed ID: 24005587
[TBL] [Abstract][Full Text] [Related]
27. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010-January 2011.
Nadkar MY; Huchche AM; Singh R; Pazare AR
J Assoc Physicians India; 2012 Oct; 60():11-3. PubMed ID: 23777018
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a rapid whole blood immunochromatographic assay for the diagnosis of Plasmodium falciparum and Plasmodium vivax malaria.
Fernando SD; Karunaweera ND; Fernando WP
Ceylon Med J; 2004 Mar; 49(1):7-11. PubMed ID: 15255320
[TBL] [Abstract][Full Text] [Related]
29. Effect of Plasmodium falciparum infection on blood parameters and their association with clinical severity in adults of Odisha, India.
Dhangadamajhi G; Panigrahi S; Roy S; Tripathy S
Acta Trop; 2019 Feb; 190():1-8. PubMed ID: 30347183
[TBL] [Abstract][Full Text] [Related]
30. Malarial hepatopathy: a 6-year retrospective observational study from Uttarakhand, North India.
Kaeley N; Ahmad S; Shirazi N; Bhatia R; Bhat NK; Srivastava S; Dhar M; Kumar M
Trans R Soc Trop Med Hyg; 2017 May; 111(5):220-225. PubMed ID: 28957471
[TBL] [Abstract][Full Text] [Related]
31. Performance of an immuno-rapid malaria Pf/Pv rapid diagnostic test for malaria diagnosis in the Western Brazilian Amazon.
Costa MRF; Barcelos ALR; Camargo MA; Melo GC; Almeida AC; Costa AGD; Sousa JDB; Melo MM; Alecrim MDGC; Lacerda MVG; Monteiro WM
Rev Soc Bras Med Trop; 2019 Jan; 52():e20170450. PubMed ID: 30652783
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the performance of CareStart Malaria Pf/Pv Combo rapid diagnostic test for the diagnosis of malaria in Jimma, southwestern Ethiopia.
Mekonnen Z; Ali S; Belay G; Suleman S; Chatterjee S
Acta Trop; 2010 Mar; 113(3):285-8. PubMed ID: 20005196
[TBL] [Abstract][Full Text] [Related]
33. Morbidity and mortality associated with Plasmodium vivax and Plasmodium falciparum infection in a tertiary care kidney hospital.
Imtiaz S; Drohlia MF; Nasir K; Hussain M; Ahmad A
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1169-76. PubMed ID: 26586055
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of SYBR green I based visual loop-mediated isothermal amplification (LAMP) assay for genus and species-specific diagnosis of malaria in
Singh R; Singh DP; Savargaonkar D; Singh OP; Bhatt RM; Valecha N
J Vector Borne Dis; 2017; 54(1):54-60. PubMed ID: 28352046
[TBL] [Abstract][Full Text] [Related]
35. Effects of Plasmodium vivax malaria in pregnancy.
Nosten F; McGready R; Simpson JA; Thwai KL; Balkan S; Cho T; Hkirijaroen L; Looareesuwan S; White NJ
Lancet; 1999 Aug; 354(9178):546-9. PubMed ID: 10470698
[TBL] [Abstract][Full Text] [Related]
36. Field evaluation of the ICT malaria P.f/P.v immunochromatographic test for diagnosis of Plasmodium falciparum and P.vivax infection in forest villages of Chhindwara, central India.
Singh N; Saxena A; Valecha N
Trop Med Int Health; 2000 Nov; 5(11):765-70. PubMed ID: 11123823
[TBL] [Abstract][Full Text] [Related]
37. The hospital- and field-based performances of the OptiMAL test, for malaria diagnosis and treatment monitoring in central India.
Singh N; Valecha N; Nagpal AC; Mishra SS; Varma HS; Subbarao SK
Ann Trop Med Parasitol; 2003 Jan; 97(1):5-13. PubMed ID: 12662417
[TBL] [Abstract][Full Text] [Related]
38. Mortality in Malaria: Intensive Care (MIMIC).
Trivedi T; Bajaj P; Moulick N; Padwal N
J Assoc Physicians India; 2018 Apr; 66(4):16-20. PubMed ID: 30347945
[TBL] [Abstract][Full Text] [Related]
39. Can hematological parameters discriminate malaria from nonmalarious acute febrile illness in the tropics?
Lathia TB; Joshi R
Indian J Med Sci; 2004 Jun; 58(6):239-44. PubMed ID: 15226575
[TBL] [Abstract][Full Text] [Related]
40. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
